OSTEOARTHRITIS: THE CURRENT STATE OF THE PROBLEM
Issue:
10
Year:
2016
The paper analyzes Russian and foreign literature on current ideas about the etiology, pathogenesis, clinic presentations, and therapy of osteoarthritis.
Keywords:
rheumatology
osteoarthritis
chondrocytes
cartilage
symptommodifying and structure-modifying drugs
References:
- Alekseeva L.I. Osteoartroz. V kn.: Revmatologija: natsional'noe rukovodctvo. Pod red. E.L. Nasonova, V.A. Nasonovoj / M.: GEOTAR-Media, 2008; c. 573–89.
- EULAR Compedium in Rheumatic Disease. Ed. J. Bijsma / BMJ, 2009; 824.2.
- Jashina E. Preparaty gialuronovoj kisloty v lechenii osteoartroza // Vrach. – 2015; 2; 58–61.
- Smith M., Ghosh P. Osteoarthritis: Current status and future directions // APLAR J. Rheum. – 1998; 2: 27–63.
- Meshkov A.P. Osteoartoz. V kn.: Diagnostika i lechenie boleznej susta vov / N. Novgorod: Izd-vo NGMA, 2000; s. 133–47.
- Alekseeva L.I. Osteoartroz ili osteoartrit? Sovremennye predstav lenija o bolezni i ee lechenii // Effektivnaja farmakoterapija. Revmatologija. Travmatologija i ortopedija. – 2014; 2: 32–3.
- Hitrov N.A. Osteoartroz ili osteoartrit – ot novyh vzgljadov v patoge neze k novomu nazvaniju // Meditsinskij sovet. – 2013; 4: 74–8.
- Pjaj L.T. Osnovy klinicheskoj revmatologii / Tallin, Valgus, 1987; s. 6–15.
- National Clinical Guideline Centre Osteoarthritis. Care and management in adults London (UK). National institute for Health and Care Exellense (NICE) // Clin. Guideline. – 2014; 177: 556.
- Mazurov V.I., Onuschenko I.A. Osteoartroz. V kn.: Klinicheskaja revma tologija. Pod red. V.I. Mazurova. 2-e izd. Pererab. i dop. / SPb: OOO Izdatel'stvo FOLIANT, 2005; s. 386–408.
- Badokin V.V. Sovremennye aspekty patogeneticheskoj terapii osteo artroza // Meditsinskij sovet. – 2013; 12: 77–81.
- Svetlova M.S. Patogeneticheskoe lechenie osteoartroza kolennyh sustavov // Sovr. revmatologija. – 2012; 3: 44–9.
- Currey H. Osteoartroz. V kn.: Klinicheskaja revmatologija: Per s angl. Pod red. N. Currey. / M.: Meditsina, 1990; s. 121–36.
- Balobanova R.M. Novye podhody k lecheniju osteoartroza kak hroniche skogo vospalitel'nogo zabolevanija // Sovrem. revmatol. – 2013; 2: 95–8.
- Roux C., Saraux A., Mazieres B. et al. Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates // Ann. Rheum. Dis. – 2008; 67 (10): 1406–11.
- Blagoejevic M., Jinks C., Jeffery A. et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis // Osteoarthritis Cartilage. – 2010; 18 (1): 24–33.
- Solovieva S., Kocmarainen O., Hirvonen A. et al. Association between interleukin-1 gene cluske polymorphisms and bilateral distol interhalangeol osteoarthritis // J. Rheum. – 2009; 36: 1977–8.
- Calich A., Domiciano D., Fuller R. Osteoarthritis: can anti-cytokine therapy play a role in treatment? // J. Clin. Rheumatol. – 2010; 29 (5): 451–5.
- Lim W., Toothman J., Miller J. et al. IL-1 beta inhibits TGF-beta in the temporomandibular joint // J. Dent. Res. – 2009; 88 (6): 557–62.
- Balobanova R.M. Rol' interlejkina-1 pri osteoartroze i vozmozhno sti ego blokirovaija // Sovrem. revmatol. – 2011; 1: 58–62.
- Shirokova L., Mokrousova M., Simionova S. i dr. Osteoartroz: kontseptsii i rol' metabolicheskih narushenij v povrezhdenii sustav-nyh komponentov // Vrach. – 2013; 10: 8–10.
- Connaghan P., Vanharanta H., Dieppe P. Is progressive osteoarthritis an atheromatous vascular disease? // Ann. Rheum. Dis. – 2005; 64: 1539–41.Kellgren J., Lawrence J. Radiological assessment of osteoarthrosis // Ann. 23. Rheum. Dis. – 1957; 16: 494–501.
- Benevolenskaja L.I., Alekseeva L.I. Diagnosticheskie kriterii osteo artroza. Sovremennye problemy revmatologii. Tez. dokladov I s'ezda revma-tologov Rossii / Orenburg, 1993; s. 191–2.
- Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee // Art. Rheum. – 1986; 29 (8): 1039–40.
- Altman R., Alarcon G., Appelrauth D. et al. The American College of . Rheumatology criteria for the classification and reporting of osteoarthritis of the hand // Art. Rheum. – 1990; 33: 1601–10.
- Altman R., Alarcon G., Appelrauth D. et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip // Art. Rheum. – 1991; 34: 505–14.
- Svetlova M.S. Podhody k lecheniju osteoartroza kolennyh sustavov na rannih stadijah zabolevanija // Meditsinskij sovet. – 2012; 2: 61–6. Alekseeva L.I. Rekomendatsii po lecheniju osteoartroza. Pod red. E.L. Nasonova / M.: GEOTAR-Media, 2010; 15 s.
- Karateev A.E. Farmakoterapija osteoartroza: otnoshenie pol'zy i riska // Effektivnaja farmakoterpija. Revmatologija. Travmatologija i orto-pedija. – 2014; 2: 22–4.
- Goncharov N.A. Lokal'naja terapija osteoartroza NPVS s chrezkozhnym mehanizmom vvedenija // Meditsinskij sovet. – 2011; 7–8; 53–7.
- Rosin G., Barbieri C., Lancas F. Diclofenac phonophoresis in human vol unteers // Ultrasound Med. Viol. – 2005; 31: 337–43.
- Alekseeva L.I. Mesto lokal'noj terapii v lechenii osteoartroza // 33. Meditsinskij sovet. – 2011; 7–8: 45–8.
- Nanda A., Nanda S., Khan Gnilrai N. Current Developments using emerging Transdermal Technologies in physical enhancenment methods // Curr. Drag. Deliv. – 2006; 3: 23–34.
- Drozdov V.N. Novyj preparat Zinaksin v lechenii osteoartroza // Rus. med. zhurnal. – 2008; 16 (4): 190–1.
- Altman R., Marcussen K. Effects of a ginger extract on knee in patients with osteoarthritis // Arthritis Rheum. – 2011; 44 (11): 2531–8.
- Briddel H., Rozetzsky A., Schlichting R. et al. A randomized placebo controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis // Osteoarthr. Cartil. – 2000; 8: 9–12.
- Tsvetkova E.S, Denisov L.N. Simptomaticheskaja terapija osteoartroza 38. kolennyh sustavov – novye vozmozhnosti // Nauchno-prakt. revmatol. – 2011; 6: 42–5.
- Solomon D., Rassen J., Glynn R. et al. The comparative safety of 39. analgesios in older adults with arthritis // Arch. Intern. Med. – 2010; 170 (22): 1968–76.
- Lesnjak O.M., Maksimov D.M., Popov A.A. i dr. Osteoartroz: medika-40. mentoznoe lechenie osteoartroza (osteoartrita) kolennyh i tazobedrennyh sustavov // Consilium Medicum. – 2005; 7 (8): 627–33.
- Beljaeva I.B. Sovremennaja farmakoterapija osteoartroza // 41. Effektivnaja farmakoterapija. Revmatologija. Travmatologija i ortope-dija. – 2015; 2; 20–4.
- Burmakova G.M., Savchenko A.M. Vnutrisustavnaja ozonoterapija v lechenii osteoartroza // Meditsinskij sovet. – 2011; 7–8: 35–8.
- Idov I.E. Aspekty primenenija ozona v meditsine // Anest. i renima tol. – 1997; 1: 90–4.
- Lohmander L. Markers of cartilage metabolism in arthrosis // Acta Orthop. Scand. – 1991; 2: 623–32.
- Pincus T. Clinical evidence for osteoarthritis as an inflammatory disease // Curr. Rheum. Rep. – 2001; 3: 524–34
- Anikin S.G., Alekseeva L.I. Primenenie preparatov gialuronovoj kisloty pri osteoartroze kolennyh sustavov // Nauchno-prakt. revmatol. – 2013; 51 (4): 439–45.
- Wang C., Lin J., Chang C. et al. Therapeutic effects of hyaluronic acid on 47. osteoarthritis of the knee. A metaanalysis of randomized controlled trials // J. Bone Jt. Surg. – 2004; 86A (3): 538–45.
- Mihalina M., Men'shikova I., Sulimov V. Primenenie preparatov 48. gialuronovoj kisloty u patsientov s osteoartrozom kolennyh sustavov // Vrach. – 2010; 5: 61–4.
- Kemper F., Gebhardt U., Meng T. et al Tolerabiliti and short-term 49. effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice // Curr. Med. Res. Opin. – 2005; 21 (8): 1261–9.
- Solov'eva I., Shesternja N., Perova N. i dr. Kombinirovannoe prime-50. nenie biopolimernogo gidrogelja i gialuronovoj kisloty pri osteoartroze (pervyj opyt) // Vrach. – 2016; 1: 12–7.
- Lygina E.V. Hondroprotektory v lechenii osteoartroza // Sovr. revma-51. tologija. – 2012; 2: 59–64.
- Vertkin A.L., Talibov O.B Lechenie osteoartroza: rol' hondroprotek-52. torov // Lechaschij vrach. – 2000; 9: 40
- Lukina G.V., Sigidin Ja.A. Alflutop v lechenii osteoartroza // Nauchno-53. prakt. revmatol. – 2001; 2: 51
- Svetlova M.S., Ignat'ev V.K. Primenenie alflutopa v lechenii bol'-54. nyh osteoartrozom // Klin. meditsina. – 2004; 5: 52–5.
- Kahan A. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee 55. osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-con-trolled trial // Arthritis Rheum. – 2009; 60 (2): 524–33.
- McAlindon T., LaValley M., Gulin J. et al. Glucozamine and chondroitin for 56. treatment of osteoarthritis a systematic quality assessment and meta-analysis // JAMA. – 2000; 283 (11): 1469–75.
- Pavelca K., Gatterova J., Olejarova M. et al. Glucosamine sulfate use and 57. delay of progression of knee osteoarthritis: a 3-years randomized, placebo-controlled, double-blind study // Arch. Intern. Med. – 2002; 162 (18); 213–23.
- Noskov S., Lavruhina A., Shirokova K. i dr. Strategija primenenija 58. hondroprotektorov pri osteoartroze // Vrach. – 2012; 10: 14–5.
- Alekseeva L.I., Koshevarova N.G., Sharapova E.P. i dr. Sravnenie 59. postojannogo i intermittirujuschego lechenija bol'nyh osteoartrozom kolen-nyh sustavov kombinirovannym preparatom Terafleks // Nauchno-prakt. rev-matol. – 2008; 3: 68–72.
- Sharapova E.P., Alekseeva L.I. Kombinirovannye simptomaticheskie 60. preparaty zamedlennogo dejstvija v terapii osteoartroza // Rus. med. zhur-nal – 2009; 17 (3): 160–5.
- Burkhard F. Leeb. Clinical Efficacy and Safety of Diacerein in 61. Osteoarthritis. – A Review // Eur. Musculoskeletiol. Rev. – 2010; 5 (1): 23–9.
- Dougados M., Nguyen M., Berdah L. et al. Evaluation of the structure 62. modifying effects of diacerein in hip osteoarthritis: ECHODIAN a three-year placebo-controlled trial Evalution of the Chondromodulation Effects of Diacerein in osteoarthritis of the hip // Arthritis Rheum. – 2001; 44 (11): 2539–47.
- Alekseeva L.I., Chichasova N.V., Koshevarova N.G. i dr. Primenenie 63. piaskledina pri osteoartroze kistej // Farmateka. – 2010; 10: 48–55.
- Chichasova N.V., Alekseeva L.I., Badokin V.A. i dr. Opyt primenenija neomyljaemyh soedinenij avokado i bobov soi (Piaskledin) v lechenii osteoartroza razlichnoj lokalizatsii // Rus. med. zhurnal. – 2014; 6: 1–19.
- Henrotin Y., Sanchez C., Deberg M. et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteo-arthritis chondrocytes // J. Rheumatol. – 2003; 30: 1825–34.
- Altinel L., Soritas Z., Kose K. et al. Treatment with unsaponifiable extracts 66. of avocado and soybean increases TGF-beta 1 and TGF-beta 2 levels in canine joint fluid // Tohoku J. Exp. Med. – 2007; 211 (2): 181–6.
- Zborovskij A.B., Stazharov M.Ju., Mozgovaja G.E. Sistemnaja enzimote rapija v lechenii revmaticheskih zabolevanij // Nauchno-prakt. revmatol. – 2003; 1: 64–9.
- Alekseeva L.I., Zajtseva L.M. Perspektivnye napravlenija terapii osteoartroza // Nauchno-prakt. revmatol. – 2014; 3: 247–50.